AGP Executive Report
Last update: 7 hours agoSmart Vapes & Addiction: Researchers warn “smart” nicotine and cannabis vapes that use apps, AI, and crypto-style rewards could make addiction harder to quit, undermining cessation efforts. Medical Cannabis Policy: New Zealand’s Misuse of Drugs (Medicinal Cannabis) Amendment Bill (No 2) heads toward a first reading, aiming to loosen provisional consent timelines and address gaps in the current scheme. CBD/Supplement Regulation: The FDA is again in the spotlight over NAC, a popular supplement, with a proposed rule reportedly delayed past its target date—another reminder that “supplement” status isn’t guaranteed. Medicinal Cannabis Business: Little Green Pharma is wrapping its first full quarter after merging with Cannatrek, with European expansion and a lingering regulatory penalty in focus. Public Health Research: A study finds stroke rates nearly doubled among adults under 55 over three decades, adding urgency to younger-adult risk screening. Drug Enforcement (Nigeria): NDLEA seized 2.55m opioid pills worth N3bn at Lagos airport and arrested suspects, plus a separate case involving 72 cocaine wraps at Enugu. Local Enforcement (Benin): Police seized nearly 20 kg of cannabis in Kétou and arrested four people. Chronic Pain Guidance: A review highlights education as central to chronic musculoskeletal pain care, aligning with CDC guidance to prioritize nonopioid and nonpharmacologic approaches.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.